Dermapharm Holding SE
DMP
Rank in Stocks
#5709
Dermapharm Holding SE, alongside its group companies, specializes in the... Dermapharm Holding SE, alongside its group companies, specializes in the off-patent branded pharmaceutical market, serving both German and international clients. The company’s operations are organized into three primary divisions: Branded Pharmaceuticals and Other Healthcare Products, Parallel Import Business, and Herbal Extracts. It undertakes the development, manufacturing, licensing, marketing, and sale of branded generic medicines, over-the-counter remedies, non-prescription natural health solutions, and various other healthcare items. Dermapharm's product range covers areas such as vitamins, minerals, nutritional supplements, dermatology, allergology, pain and inflammation management, cardiovascular support, gynecology, and urology, prominently featuring brands like Dekristol, Dekristolvit, Allergovit, and Tromcardin. Additionally, the company provides medical devices including bite away and Herpotherm, as well as specific pharmaceutical preparations like Momekort, a nasal spray for allergy symptoms, and Azedil, which functions as a nasal spray or eye drop. It also manages the importation of originator pharmaceuticals under the axicorp brand. Furthermore, Dermapharm supplies herbal extracts and natural active ingredients for application in phytopharmaceuticals, nutraceuticals, and cosmetics. Its clientele encompasses pharmaceutical wholesalers, retail pharmacies, hospitals, and health food stores. Founded in 1991 and headquartered in Grünwald, Germany, Dermapharm Holding SE is a subsidiary of Themis Beteiligungs-Aktiengesellschaft.
Share Price
$43.04
Last synced: 2026-11-09
Market Cap
$2.13B
Change (1 day)
1.60%
Change (1 year)
9.21%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Dermapharm Holding SE (DMP)
Category
Healthcare
Dividend yield history for Dermapharm Holding SE (DMP)
Dermapharm Holding SE (stock symbol: DMP) dividend yield (TTM) as of 2025: 2.29%
Average dividend yield, last 5 years : 2.76%
Average dividend yield, last 5 years : 2.76%
Dividend yield history for Dermapharm Holding SE (DMP) from 2013 to 2026
Dividend Yield at the end of each year (TTM)
| Year | Dividend Yield | Change |
|---|---|---|
| 2026 (TTM) | 2.28% | -0.44% |
| 2025 | 2.29% | 1.33% |
| 2024 | 2.26% | -8.87% |
| 2023 | 2.48% | -57.09% |
| 2022 | 5.78% | 483.84% |
| 2021 | 0.99% | -29.29% |
| 2020 | 1.40% | -27.84% |
| 2019 | 1.94% | 0.00% |
| 2018 | 0.00% | 0.00% |
| 2017 | 0.00% | 0.00% |
| 2016 | 0.00% | -100.00% |
| 2015 | 0.01% | -97.50% |
| 2014 | 0.40% | 0.00% |
| 2013 | 0.00% | 0.00% |
Dividend yields (TTM) for similar companies or competitors
| Company | Dividend Yield | Country |
|---|---|---|
| 1.63% |
DE
|
|
| 1.45% |
DE
|
|
| 3.04% |
JP
|
|
| 0.18% |
CH
|
|
| 0.00% |
IL
|
Questions about Dermapharm Holding SE's dividend yield
What is Dermapharm Holding SE's dividend yield?
Dermapharm Holding SE's dividend yield is 2.28%, as of Nov 2026.
What was Dermapharm Holding SE's dividend yield in 2025?
In 2025, Dermapharm Holding SE's dividend yield was 2.29%, compared with 2.26% in 2024.
How has Dermapharm Holding SE's dividend yield changed since 2020?
From 2020 to 2025, Dermapharm Holding SE's dividend yield was highest in 2022 (5.78%) and lowest in 2021 (0.99%).
How does Dermapharm Holding SE's dividend yield compare with similar companies?
Dermapharm Holding SE's dividend yield (2.28%) is higher than that of 4 of the 5 similar companies listed above. The highest among them is Takeda Pharmaceutical Company Limited, with 3.04%.